论文部分内容阅读
目的探讨慢性阻塞性肺病II型呼吸衰竭治疗方法及效果。方法选取本院近两年收治的74例慢性阻塞性肺病Ⅱ型呼吸衰竭患者随机分为观察组(37例)与参考组(37例),参考组患者采用常规临床治疗,观察组患者在常规治疗基础上采用纳洛酮治疗,比较两组患者治疗前后血气分析、临床治疗效果及不良反应发生情况。结果相较治疗前两组患者血气分析均有明显改善(P<0.05),观察组患者PO2、PCO2指标改善情况明显优于参考组(P<0.05);观察组患者治疗总有效率为94.6%,参考组患者治疗总有效率为67.6%,比较差异有统计学意义(P<0.05);两组患者治疗期间均未出现严重不良反应(P>0.05)。结论在常规治疗基础上给予患者纳洛酮治疗有助于促进气血指标的改善,安全性高,可推广使用。
Objective To investigate the treatment methods and effects of type II respiratory failure in patients with chronic obstructive pulmonary disease. Methods Seventy-two patients with COPD type Ⅱ respiratory failure treated in our hospital in the past two years were randomly divided into observation group (37 cases) and reference group (37 cases). Patients in reference group were treated with routine clinical treatment, Naloxone treatment was used on the basis of treatment, blood gas analysis, clinical treatment and adverse reactions before and after treatment were compared between the two groups. Results Compared with the reference group (P <0.05), the improvement of PO2 and PCO2 in the observation group was significantly better than that in the reference group (P <0.05). The total effective rate in the observation group was 94.6% , And the total effective rate of reference group patients was 67.6%, with significant difference (P <0.05). No serious side effects occurred in both groups during treatment (P> 0.05). Conclusion The naloxone treatment given to patients on the basis of routine treatment can help improve the improvement of qi and blood parameters, which is safe and can be widely used.